SLBT logo

SL Science Holding Ltd

SLBT
Healthcare|Biotechnology|US
$0.94
+0.04 (+4.16%)

Clinical Trials (2)

TrialConditionsPhaseStatusEnrollmentDesignDrug
NCT01654341
Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes
Type 2 Diabetes Mellitus
N/A
Completed986RCT, Open-label—
NCT07717671
VIPPSTAR-G1 Digital Early Intervention for Visual Impairment
Visual Impairment, Cerebral Visual Impairment
N/A
Not Yet Recruiting150RCT, Single-blind—